Healthcare Sector

Members of Parliament invested in the Healthcare Sector

157 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£149.59	245.95%	£242,166.96
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£149.59	224.28%	£226,995.44
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,309.79	10.69%	£77,485.47
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,309.79	223.37%	£226,356.97
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,309.79	79.33%	£125,530.22
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,309.79	13.04%	£79,130.74
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,309.79	399.15%	£349,403.83
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,309.79	9.49%	£76,644.07
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,309.79	145.70%	£171,992.86
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,309.79	11.62%	£78,135.30
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,309.79	30.11%	£91,073.83
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,309.79	66.27%	£116,387.92
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,309.79	353.02%	£317,115.49
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.68	-79.46%	£14,380.66
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£50.50	35.06%	£94,544.00
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£50.50	18.05%	£82,632.07
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£50.50	28.24%	£89,766.38
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£50.50	19.36%	£83,549.99
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£50.50	27.88%	£89,516.33
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£50.50	12.85%	£78,994.41
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£50.50	14.72%	£80,304.41
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£50.50	35.14%	£94,594.60
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£222.51	34.83%	£94,381.02
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£222.51	81.43%	£127,003.42
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£222.51	206.11%	£214,275.68
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£222.51	265.19%	£255,632.69
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£222.51	37.59%	£96,312.76
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£175.66	143.45%	£170,415.45
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£369.74	46.02%	£102,210.72
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£369.74	-24.55%	£52,813.53
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£369.74	-31.25%	£48,122.64
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£369.74	-28.65%	£49,945.58
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£369.74	-37.80%	£43,542.73
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,319.29	96.18%	£137,325.91
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£474.46	13.47%	£79,428.42
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£474.46	3.31%	£72,319.92
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£474.46	-18.71%	£56,905.28
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£474.46	2.47%	£71,726.41
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£474.46	-0.62%	£69,567.46
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£115.40	-81.16%	£13,186.42
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£115.40	-63.94%	£25,243.75
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£45.80	26.00%	£88,198.08
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£45.80	-54.96%	£31,527.19
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£45.80	-62.69%	£26,118.13
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£45.80	-65.99%	£23,808.11
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£87.31	-48.06%	£36,357.52
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£87.31	-46.38%	£37,536.54
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£145.39	64.51%	£115,153.88
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£145.39	120.13%	£154,088.55
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£145.39	169.04%	£188,324.77
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£158.00	-30.55%	£48,615.38
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£318.30	26.38%	£88,469.32
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£318.30	2.79%	£71,955.43
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£318.30	24.43%	£87,103.20
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£318.30	5.05%	£73,534.65
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£318.30	3.01%	£72,106.79
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£87.01	244.37%	£241,060.54
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£87.01	-20.04%	£55,970.41
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£87.01	164.47%	£185,127.65
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£14.80	-85.38%	£10,237.15
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£26.48	35.49%	£94,839.53
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.48	-8.76%	£63,867.09
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£30.05	32.93%	£93,054.46
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£30.05	43.23%	£100,260.28
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£350.49	302.45%	£281,712.03
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£294.23	323.84%	£296,688.29
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£294.23	6.99%	£74,894.91
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£44.85	-6.17%	£65,679.92
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£44.85	-18.38%	£57,133.75
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£15.47	20.77%	£84,535.52
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£77.96	-22.64%	£54,155.01
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£87.36	9.97%	£76,978.85
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£37.43	-60.71%	£27,504.72
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£168.39	-38.49%	£43,058.63
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£202.71	26.06%	£88,238.92
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£453.49	63.21%	£114,249.77
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£453.49	29.28%	£90,493.74
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£453.49	-17.74%	£57,580.81
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£429.02	1,283.04%	£968,130.21
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£26.30	5.16%	£73,609.96
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,356.00	-12.02%	£61,583.27
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£572.20	1,809.88%	£1,336,915.96
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£974.96	33.31%	£93,319.29
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£974.96	2.07%	£71,448.82
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,410.50	-30.38%	£48,733.96
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£0.92	-97.87%	£1,490.88
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£827.50	48.56%	£103,994.61
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£7.79	456.43%	£389,500.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.40	25.00%	£87,500.00
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.73	-30.10%	£48,932.69
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£43.03	185.88%	£200,116.29
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.55	-95.42%	£3,209.50
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£12.51	17.80%	£82,457.63
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£12.25	8.89%	£76,222.22
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£50.20	66.89%	£116,821.81
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£48.54	-56.65%	£30,342.92
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£331.83	-1.27%	£69,110.89
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.10	-67.59%	£22,687.75
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£176.30	-15.04%	£59,474.70
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£176.30	-35.47%	£45,172.03
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.47	-98.17%	£1,278.85
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£81.00	-27.68%	£50,625.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£81.00	57.28%	£110,097.09
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.75	-87.50%	£8,750.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£4.09	3.54%	£72,481.01

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.